The Uromigos

The Uromigos

Health EN ↓ 485 Folgen

Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Besuch unbedingt die Website des Podcasts und unterstütze die Macher: www.uromigos.org

Autor

The Uromigos

Kategorie

Health

Podcast-Website

www.uromigos.org

Neueste Folge

5. Okt 2026

Wo hören?

Podcasts in der App Replaio Radio Bald verfügbar

Podcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts

Bei Google Play herunterladen Kostenlos installieren Android fast 10 Mio. Downloads · Bewertung 4,8 iOS bald

Folgen

Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer 08.06.2021

Nizar Tannir describes the results of this trial with a novel glutaminase inhibitor. 

Episode 110: PEACE1 - Triplet therapy in prostate cancer 08.06.2021

Karim Fizazi describes the results of this randomised, potentially practice-changing trial. 

Episode 109: Adjuvant pembrolizumab in renal cancer 07.06.2021

Toni Choueiri describes the KN564 study in detail.

Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer 07.06.2021

Tom and Peter continue to see things differently - has the data changed things? 

Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing 07.06.2021

Matt Galsky describes his Phase 2 study and gives a vision of the future.

Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021 07.06.2021

Andrea Necchi gives a summary of the three abstracts. 

Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer 07.06.2021

Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.

Episode 104: Plenary Session 177lu-PSMA-617 in Prostate Cancer 06.06.2021

Mike Morris does his stuff. 

Episode 103: Targeting the microbiome to increase the activity of immune therapy in renal cancer 06.06.2021

Monty Pal describes a small randomised trial of ipi/nivo plus CMB588.

Episode 102: Adjuvant therapy in melanoma - how it will help inform the renal community 28.05.2021

James Larkin describes learning from adjuvant immune checkpoint inhibitors in melanoma. 

Episode 101: The Uromigos Paper of the Month - Belzutifan in renal cancer 26.05.2021

Eric Jonasch gives an overview of the recent Nature Medicine publication. 

Episode 100: The Uromigos 100th Podcast - Looking to the Future 21.05.2021

Chris Sweeney, Kala Sridhar and David McDermott discuss the future. 

Episode 99: Navigating social media from a patients' perspective 19.05.2021

Dena Battle is the co-founder and president of KCure and a passionate kidney cancer patient advocate. 

Episode 98: Bladder cancer from a patient perspective 19.05.2021

Dr. Lydia Makaroff, Vice President of the World Bladder Cancer Patient Coalition, discusses key issues for bladder cancer. 

Episode 97: Sacituzumab Govitecan in Bladder Cancer 04.05.2021

Petros Grivas discusses the recent accelerated approval and JCO paper data.

Episode 96: ODAC Bladder Cancer Accelerated Approval Meetings with Andrea Apolo 28.04.2021

Andrea Apolo discusses highlights from the April 28th meeting. 

Episode 95: ODAC Overview and Bladder Accelerated Approval Meetings with Jorge Garcia 28.04.2021

Jorge Garcia discusses the pembrolizumab and atezolizumab bladder cancer dangling accelerated approvals and the ODAC process

Episode 94: EIKCS Summary of Day 1 23.04.2021

Samra Turajlic summarised the meetings and looks forward to Day 2...

Episode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancer 14.04.2021

Silke Gillessen discusses the back to back JCO papers on this topic. 

Episode 92: Second line therapy in advanced RCC 09.04.2021

Viktor Grünwald discusses treatment for progression of disease after front lines PD1 based therapy. 

Episode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancer 26.03.2021

Joaquim Bellmunt describes this study as well as adjuvant nivolumab and ctDNA in bladder cancer. 

Episode 90: The Uromigos Podcast with QOL Expert David Cella 12.03.2021

Everything you wanted to know about quality of life assessment in cancer but were too afraid to ask. 

Episode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancer 04.03.2021

David McDermott describes these back to back JCO publications. 

Episode 88: Career Development in Academic Oncology Part 3 - Walter Stadler 26.02.2021

In these podcasts, we explore academic career development with individuals in different stages of their career. 

Episode 87: Career Development in Academic Oncology Part 2 - Monty Pal 26.02.2021

In these podcasts, we explore academic career development with individuals at different stages in their career. 

Höre den Podcast The Uromigos in Replaio

Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht

Bei Google Play herunterladen

Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet